https://endpts.com/amgen-rolls-out-data-for-kras-inhibitor-combo-study-in-colorectal-cancer-hoping-to-move-on-from-ugly-early-results/
Amgen rushing to get their Kras drug into combo studies. It is the only approved Kras drug on the market. This article is a good read. it shows what the drug needs to achieve for an FDA fast track approval.
What a truely exciting period PTX is having at the moment.
Ann: PTX-100 trial advances following successful Phase 1b, page-284
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
